KOSDAQ - Delayed Quote KRW
OliX Pharmaceuticals, Inc (226950.KQ)
52,000.00
+1,100.00
+(2.16%)
At close: 3:30:15 PM GMT+9
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-28,044,990.53
-28,044,990.53
-21,168,432.07
-30,682,858.18
-19,053,575.33
Investing Cash Flow
973,555.86
973,555.86
34,366,401.73
-54,763,807.19
15,473,356.50
Financing Cash Flow
18,541,377.36
18,541,377.36
-6,110,382.40
56,048,064.99
26,555,202.82
End Cash Position
3,883,390.14
3,883,390.14
11,982,762.22
4,930,267.85
34,336,736.23
Capital Expenditure
-14,079,686.99
-14,079,686.99
-9,068,217.15
-2,534,613.52
-26,285,107.70
Issuance of Capital Stock
--
--
474,650
57,000,152
5,206,275
Issuance of Debt
19,700,000
19,700,000
23,600,000
--
20,000,000
Repayment of Debt
--
--
-29,050,000
--
--
Free Cash Flow
-42,124,677.52
-42,124,677.52
-30,236,649.22
-33,217,471.70
-45,338,683.03
12/31/2021 - 7/18/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade